MAPT and Alzheimer disease: Additionally, the binding of the anti-pMcm2 antibody to NFT withinAD brains was striking and showed some co-localization with phosphorylated tauon adjacent sections of AD tissue In particular, many of the same NFT andsenile plaques demonstrated co-localization of tau with pMcm2 in all AD cases(Figure 2).